TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy

References

• Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J Clinicians. 2021;71(3):209–249. doi: 10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6. doi: 10.1038/s41572-020-00240-3
   PubMed Web of Science ®Google Scholar
• Shalem O, Sanjana NE, Hartenian E, et al. Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells. Science. 2014;343(6166):84–87. doi: 10.1126/science.1247005
   PubMed Web of Science ®Google Scholar
• Joung J, Konermann S, Gootenberg JS, et al. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening. Nat Protoc. 2017;12(4):828–863. doi: 10.1038/nprot.2017.016
   PubMed Web of Science ®Google Scholar
• Song C, Li Y, Mou H, et al. Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice. Gastroenterology. 2017;152(5):1161–1173. doi: 10.1053/j.gastro.2016.12.002
   PubMed Web of Science ®Google Scholar
• Wei L, Lee D, Law CT, et al. Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC. Nat Commun. 2019;10(1):4681. doi: 10.1038/s41467-019-12606-7
   PubMed Web of Science ®Google Scholar
• Chen J, Xu Z, Huang H, et al. SETD1A drives stemness by reprograming epigenetic landscape in hepatocellular carcinoma stem cells. JCI Insight. 2023;8(18):e168375. doi: 10.1172/jci.insight.168375
   PubMed Web of Science ®Google Scholar
• Wang R, Chen L, Chen H, et al. MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients. Gastroenterology. 2013;145(6):1436–1448. doi: 10.1053/j.gastro.2013.08.009
   PubMed Web of Science ®Google Scholar
• Tiemin P, Fanzheng M, Peng X, et al. MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways. J Hepatol. 2020;72(4):761–773. doi: 10.1016/j.jhep.2019.11.021
   PubMed Web of Science ®Google Scholar
• Chong Z, Ohnishi S, Yusa K, et al. Pooled extracellular receptor-ligand interaction screening using CRISPR activation. Genome Biol. 2018;19(1):205. doi: 10.1186/s13059-018-1581-3
   PubMedGoogle Scholar
• Matsuo Y. Introducing thioredoxin-related transmembrane proteins: Emerging roles of human TMX and clinical implications. Antioxid Redox Signal. 2022;36(13–15):984–1000. doi: 10.1089/ars.2021.0187
   PubMed Web of Science ®Google Scholar
• Oguro A, Imaoka S. Thioredoxin-related transmembrane protein 2 (TMX2) regulates the Ran protein gradient and importin-β-dependent nuclear cargo transport. Sci Rep. 2019;9(1):15296. doi: 10.1038/s41598-019-51773-x
   PubMedGoogle Scholar
• Lynes EM, Bui M, Yap MC, et al. Palmitoylated TMX and calnexin target to the mitochondria-associated membrane. The EMBO Journal. 2012;31(2):457–470. doi: 10.1038/emboj.2011.384
   PubMed Web of Science ®Google Scholar
• Vandervore LV, Schot R, Milanese C, et al. TMX2 is a crucial regulator of cellular redox state, and its dysfunction causes severe brain developmental abnormalities. The American Journal Of Human Genetics. 2019;105(6):1126–1147. doi: 10.1016/j.ajhg.2019.10.009
   PubMed Web of Science ®Google Scholar
• Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer. 2017;17(9):528–542. doi: 10.1038/nrc.2017.53
   PubMed Web of Science ®Google Scholar
• Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147(4):728–741. doi: 10.1016/j.cell.2011.10.026
   PubMed Web of Science ®Google Scholar
• Cheung EC, Vousden KH. The role of ROS in tumour development and progression. Nat Rev Cancer. 2022;22(5):280–297. doi: 10.1038/s41568-021-00435-0
   PubMed Web of Science ®Google Scholar
• Scherz-Shouval R, Elazar Z. Regulation of autophagy by ROS: physiology and pathology. Trends Biochem Sci. 2011;36(1):30–38. doi: 10.1016/j.tibs.2010.07.007
   PubMed Web of Science ®Google Scholar
• Meyers RM, Bryan JG, McFarland JM, et al. Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells. Nat Genet. 2017;49(12):1779–1784. doi: 10.1038/ng.3984
   PubMed Web of Science ®Google Scholar
• Lim H, Sohn I, Deng S, et al. Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling. Ann Surg Oncol. 2013;20(12):3747–3753. doi: 10.1245/s10434-013-3070-y
   PubMed Web of Science ®Google Scholar
• Lamb JR, Zhang C, Xie T, et al. Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting. PLOS ONE. 2011;6(7):e20090. doi: 10.1371/journal.pone.0020090
   PubMed Web of Science ®Google Scholar
• Mizushima N, Levine B, Cuervo AM, et al. Autophagy fights disease through cellular self-digestion. Nature. 2008;451(7182):1069–1075. doi: 10.1038/nature06639
   PubMed Web of Science ®Google Scholar
• Xia H, Green DR, Zou W. Autophagy in tumour immunity and therapy. Nat Rev Cancer. 2021;21(5):281–297. doi: 10.1038/s41568-021-00344-2
   PubMed Web of Science ®Google Scholar
• Wang S, Wu H, Yasui Y, et al. Nucleoporin POM121 signals TFEB-mediated autophagy via activation of SIGMAR1/sigma-1 receptor chaperone by pridopidine. Autophagy. 2023;19(1):126–151. doi: 10.1080/15548627.2022.2063003
   PubMed Web of Science ®Google Scholar
• Perera RM, Stoykova S, Nicolay BN, et al. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism. Nature. 2015;524(7565):361–365. doi: 10.1038/nature14587
   PubMed Web of Science ®Google Scholar
• Geisler S, Holmström KM, Skujat D, et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol. 2010;12(2):119–131. doi: 10.1038/ncb2012
   PubMed Web of Science ®Google Scholar
• Sun Y, Vashisht AA, Tchieu J, et al. Voltage-dependent anion channels (VDACs) recruit Parkin to defective mitochondria to promote mitochondrial autophagy. J Biol Chem. 2012;287(48):40652–40660. doi: 10.1074/jbc.M112.419721
   PubMed Web of Science ®Google Scholar
• Narendra DP, Jin SM, Tanaka A, et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLOS Biol. 2010;8(1):e1000298. doi: 10.1371/journal.pbio.1000298
   PubMed Web of Science ®Google Scholar
• Shoshan-Barmatz V, Keinan N, Zaid H. Uncovering the role of VDAC in the regulation of cell life and death. J Bioenerg Biomembr. 2008;40(3):183–191. doi: 10.1007/s10863-008-9147-9
   PubMed Web of Science ®Google Scholar
• Chin HS, Li MX, Tan I, et al. VDAC2 enables BAX to mediate apoptosis and limit tumor development. Nat Commun. 2018;9(1):4976. doi: 10.1038/s41467-018-07309-4
   PubMedGoogle Scholar
• Ma SB, Nguyen TN, Tan I, et al. Bax targets mitochondria by distinct mechanisms before or during apoptotic cell death: a requirement for VDAC2 or Bak for efficient Bax apoptotic function. Cell Death Differ. 2014;21(12):1925–1935. doi: 10.1038/cdd.2014.119
   PubMed Web of Science ®Google Scholar
• Niu X, Brahmbhatt H, Mergenthaler P, et al. A small-molecule inhibitor of bax and bak oligomerization prevents genotoxic cell death and promotes neuroprotection. Cell Chem Biol. 2017;24(4):493–506. doi: 10.1016/j.chembiol.2017.03.011
   PubMed Web of Science ®Google Scholar
• Zheng Y, Huang C, Lu L, et al. STOML2 potentiates metastasis of hepatocellular carcinoma by promoting PINK1-mediated mitophagy and regulates sensitivity to lenvatinib. J Hematol Oncol. 2021;14(1):16. doi: 10.1186/s13045-020-01029-3
   PubMed Web of Science ®Google Scholar
• Zong W, Rabinowitz JD, White E. Mitochondria and Cancer. Mol Cell. 2016;61(5):667–676. doi: 10.1016/j.molcel.2016.02.011
   PubMed Web of Science ®Google Scholar
• Zhang X, Cheng X, Yu L, et al. MCOLN1 is a ROS sensor in lysosomes that regulates autophagy. Nat Commun. 2016;7(1):12109. doi: 10.1038/ncomms12109
   PubMedGoogle Scholar
• Mahipal A, Malafa M. Importins and exportins as therapeutic targets in cancer. Pharmacol Ther. 2016;164:135–143. doi: 10.1016/j.pharmthera.2016.03.020
   PubMed Web of Science ®Google Scholar
• Wu H, Wang T, Liu Y, et al. Mitophagy promotes sorafenib resistance through hypoxia-inducible ATAD3A dependent Axis. J Exp Clin Cancer Res. 2020;39(1):274. doi: 10.1186/s13046-020-01768-8
   PubMed Web of Science ®Google Scholar